TP53 and Miyoshi myopathy: For example, TP53 mutation, a prevalent tumor suppressor gene mutation, was frequently observed in the MH subgroup with a mutation rate of 73%, compared to mutation rates of 14% in the ML subgroup and 39% in the MM subgroup.